|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 146.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 753.37 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 769.00 °F. TCC ( 409.40 °C. ) (est)
|
| logP (o/w): | 4.350 |
| Soluble in: |
| | water, 0.08663 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-child TDLo 450 mg/kg/90D- ENDOCRINE: EVIDENCE OF THYROID HYPOFUNCTION British Medical Journal. Vol. 293, Pg. 993, 1986.
intravenous-dog LD50 23300 ug/kg Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
oral-dog LD50 178 mg/kg Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
intravenous-guinea pig LD50 23300 ug/kg Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
oral-guinea pig LD50 178 mg/kg Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
oral-man LDLo 45 mg/kg/17D-I BEHAVIORAL: COMA
LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" Gut. Vol. 26, Pg. 636, 1986.
oral-man TDLo 49 mg/kg/17D-I LIVER: OTHER CHANGES Gastroenterology. Vol. 86, Pg. 503, 1984.
intraperitoneal-mouse LD50 2937 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
intravenous-mouse LD50 32 mg/kg Antimicrobial Agents and Chemotherapy. Vol. 33, Pg. 895, 1989.
oral-mouse LD50 618 mg/kg Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
intraperitoneal-rat LD50 1474 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
intravenous-rat LD50 86 mg/kg Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 23, Pg. 1, 1982.
oral-rat LD50 166 mg/kg Medicamentos de Actualidad. Vol. 17, Pg. 373, 1981.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 > 4000 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
subcutaneous-rat LD50 > 2400 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 474, 1987.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for ketoconazole usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for ketoconazole flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| EPI System: | View |
| ClinicalTrials.gov: | search |
| Daily Med: | search |
| AIDS Citations: | Search |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 47576 |
| National Institute of Allergy and Infectious Diseases: | Data |
| WGK Germany: | 3 |
| | 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone |
| Chemidplus: | 0065277421 |
| RTECS: | TK7912300 for cas# 65277-42-1 |
References:
| | 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 47576 |
| Pubchem (sid): | 135007018 |
Other Information:
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| CHEBI: | View |
| CHEMBL: | View |
| KEGG (GenomeNet): | D00351 |
| HMDB (The Human Metabolome Database): | HMDB12242 |
| FooDB: | FDB028884 |
| MedlinePlusSupp: | View |
| ChemSpider: | View |
| Wikipedia: | View |
Formulations/Preparations: •tablets as 0.2 g; 2% solutions, ointments, and cream preparations.
•trade names: candoral, cetonax, fitonal, fungarest, fungicil, fungo-hubber, fungoral, ketazol, ketoderm, ketoisdin, ketonan, ketoral, micoral, micotek, micoticum, nizoral, nizshampoo, oromycosal, oronazol, panfungol, rofenid, terzolin.
•topical: cream 2% ketoconazole, (taro, teva), shampoo: 1 nizoral a-d, (mcneil), 2% nizoral, (mcneil).
•oral: tablets: 200 mg ketoconazole tablets (scored), aaipharma, mutual, mylan, sidmak, pliva, taro, teva, torpharm); nizoral ( with povidone; scored), (janssen).
|
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| cis-1- | acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1h-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine | | 1- | acetyl-4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine | | 1-[4-[4-[[(2S,4R)-2-(2,4- | dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | | | ethanone, 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]- | | 1-(4-(4-(((2S,4R)-2-((1H- | imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethanone | | (-)- | ketoconazole | | (2S,4R)- | ketoconazole | | | piperazine, (-)-1-acetyl-4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]- |
Articles:
| PubMed: | Liver injury associated with ketoconazole: Review of the published evidence. |
| PubMed: | Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers. |
| PubMed: | Combined administration of antibiotics and direct oral anticoagulants: a renewed indication for laboratory monitoring? |
| PubMed: | Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes. |
| PubMed: | Quantitative modelling to estimate the transfer of pharmaceuticals through the food production system. |
| PubMed: | Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies. |
| PubMed: | Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer. |
| PubMed: | Fungal toenail infections. |
| PubMed: | CYP3A4 activity reduces the cytotoxic effects of okadaic acid in HepaRG cells. |
| PubMed: | Ketoconazole in Cushing's disease: is it worth a try? |
| PubMed: | Synthesis and synergistic, additive inhibitory effects of novel spiro derivatives against ringworm infections. |
| PubMed: | Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus. |
| PubMed: | Implantation phaeohyphomycosis caused by a non-sporulating Chaetomium species. |
| PubMed: | In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 threshold. |
| PubMed: | Candidiasis (oropharyngeal). |
| PubMed: | T-2 toxin is hydroxylated by chicken CYP3A37. |
| PubMed: | Ketoconazole modulates the infectivity of Ichthyophonus sp. (Mesomycetozoa) in vivo in experimentally injected European sea bass. |
| PubMed: | Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives. |
| PubMed: | Predictive value of cell assays for developmental toxicity and embryotoxicity of conazole fungicides. |
| PubMed: | Utility of a column-switching LC/MS/MS method in cytochrome P450 inhibition assays using human liver microsomes. |
| PubMed: | Clinical pharmacology of axitinib. |
| PubMed: | Skin conditions: common skin rashes in infants. |
| PubMed: | Food-drug interactions: effect of capsaicin on the pharmacokinetics of simvastatin and its active metabolite in rats. |
| PubMed: | Inhibition of CYP3A4 by 6',7'-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells. |
| PubMed: | Uptake of oxytetracycline, sulfamethoxazole and ketoconazole from fertilised soils by plants. |
| PubMed: | Telaprevir: pharmacokinetics and drug interactions. |
| PubMed: | Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics. |
| PubMed: | [The new anticoagulants - their role in secondary prevention of thromboembolism after stroke]. |
| PubMed: | Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects. |
| PubMed: | A co-culture system of human intestinal Caco-2 cells and lymphoblastoid TK6 cells for investigating the genotoxicity of oral compounds. |
| PubMed: | Screening for modulatory effects on steroidogenesis using the human H295R adrenocortical cell line: a metabolomics approach. |
| PubMed: | Evaluation of the antifungal activity and modulation between Cajanus cajan (L.) Millsp. leaves and roots ethanolic extracts and conventional antifungals. |
| PubMed: | Comparison of three fluorescent CYP3A substrates in two vertebrate models: pig and Atlantic salmon. |
| PubMed: | Candidiasis (oropharyngeal). |
| PubMed: | Tolbutamide hydroxylation by hepatic microsomes from Atlantic salmon (Salmo salar L.). |
| PubMed: | Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation. |
| PubMed: | Enhancement of β-carotene production by over-expression of HMG-CoA reductase coupled with addition of ergosterol biosynthesis inhibitors in recombinant Saccharomyces cerevisiae. |
| PubMed: | A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects. |
| PubMed: | Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant. |
| PubMed: | Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report. |
| PubMed: | Fungal toenail infections. |
| PubMed: | Broadening horizons in medical management of prostate cancer. |
| PubMed: | Antimicrobial properties of Quercus ilex L. proanthocyanidin dimers and simple phenolics: evaluation of their synergistic activity with conventional antimicrobials and prediction of their pharmacokinetic profile. |
| PubMed: | Para-nitrophenol hydroxylation by fish liver microsomes: kinetics and effect of selective cytochrome P450 inhibitors. |
| PubMed: | Hepatic cytochrome P450s attenuate the cytotoxicity induced by leflunomide and its active metabolite A77 1726 in primary cultured rat hepatocytes. |
| PubMed: | Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic. |
| PubMed: | Laser phototherapy for Stevens-Johnson syndrome: a case report. |
| PubMed: | Comparison of the substrate kinetics of pig CYP3A29 with pig liver microsomes and human CYP3A4. |
| PubMed: | Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillation. |
| PubMed: | Bioequivalence study of two formulations of 100 mg capsule of itraconazole. Quantification by tandem mass spectrometry. |
| PubMed: | Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats. |
| PubMed: | A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and patients. |
| PubMed: | Seborrhoeic dermatitis. |
| PubMed: | Prescriber compliance with black box warnings in older adult patients. |
| PubMed: | Justification for the use of Ocimum gratissimum L in herbal medicine and its interaction with disc antibiotics. |
| PubMed: | Estimation of intragastric drug solubility in the fed state: comparison of various media with data in aspirates. |
| PubMed: | Clinical pharmacokinetics and pharmacodynamics of solifenacin. |
| PubMed: | PCOS. |
| PubMed: | The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport. |
| PubMed: | Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power. |
| PubMed: | Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. |
| PubMed: | Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. |
| PubMed: | The need for multiple doses of 400 mg ketoconazole as a precipitant inhibitor of a CYP3A substrate in an in vivo drug-drug interaction study. |
| PubMed: | Quantitative evaluation of pharmacokinetic inhibition of CYP3A substrates by ketoconazole: a simulation study. |
| PubMed: | CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. |
| PubMed: | Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions. |
| PubMed: | Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers. |
| PubMed: | Fungal toenail infections. |
| PubMed: | Endocrine-disrupting properties in vivo of widely used azole fungicides. |
| PubMed: | 1H NMR monitoring of the canine metabolic profile after oral administration of xenobiotics using multivariate statistics. |
| PubMed: | Seborrhoeic dermatitis. |
| PubMed: | Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. |
| PubMed: | Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. |
| PubMed: | The H295R system for evaluation of endocrine-disrupting effects. |
| PubMed: | Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. |
| PubMed: | Repeated 28-day oral toxicity study of ketoconazole in rats based on the draft protocol for the "Enhanced OECD Test Guideline No. 407" to detect endocrine effects. |
| PubMed: | Clinical pharmacokinetics of ranolazine. |
| PubMed: | The clinical pharmacokinetics of darifenacin. |
| PubMed: | Secondary hormonal therapy for advanced prostate cancer. |
| PubMed: | Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections. |
| PubMed: | Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial. |
| PubMed: | pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model. |
| PubMed: | Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine. |
| PubMed: | Exposure-response relationships and drug interactions of sirolimus. |
| PubMed: | Population-based case-control study of oral ketoconazole treatment for birth outcomes. |
| PubMed: | Intestinal metabolism of PAH: in vitro demonstration and study of its impact on PAH transfer through the intestinal epithelium. |
| PubMed: | Effect of fruit juices on the oral bioavailability of fexofenadine in rats. |
| PubMed: | Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. |
| PubMed: | Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia. |
| PubMed: | The systemic treatment of onychomycosis. |
| PubMed: | Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. |
| PubMed: | CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. |
| PubMed: | Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds. |
| PubMed: | Desloratadine: A preclinical and clinical overview. |
| PubMed: | Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam. |
| PubMed: | Lopinavir/ritonavir: a review of its use in the management of HIV infection. |
| PubMed: | Determination of clotrimazole in mice plasma by capillary electrophoresis. |
| PubMed: | Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. |
| PubMed: | Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. |
| PubMed: | Atopic dermatitis and fungi. |
| PubMed: | Application of modeling and simulation to integrate clinical pharmacology knowledge across a new drug application. |
| PubMed: | Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl- 2(2'-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol. |
| PubMed: | Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo. |
| PubMed: | Ketoconazole suppresses food restriction-induced increases in heroin self-administration in rats: sex differences. |
| PubMed: | Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. |
| PubMed: | Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. |
| PubMed: | Effects of ketoconazole on the acquisition of intravenous cocaine self-administration under different feeding conditions in rats. |
| PubMed: | Desloratadine: A new, nonsedating, oral antihistamine. |
| PubMed: | The pharmacologic profile of desloratadine: a review. |
| PubMed: | Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. |
| PubMed: | Oral griseofulvin remains the treatment of choice for tinea capitis in children. |
| PubMed: | Ketoconazole reduces low dose cocaine self-administration in rats. |
| PubMed: | Drug interactions with cisapride: clinical implications. |
| PubMed: | Cardiac effects of ebastine and other antihistamines in humans. |
| PubMed: | Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam. |
| PubMed: | Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. |
| PubMed: | Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. |
| PubMed: | Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. |
| PubMed: | Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole. |
| PubMed: | Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver. |
| PubMed: | A neuroendocrine role in cocaine reinforcement. |
| PubMed: | Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. |
| PubMed: | Temporal decline in filling prescriptions for terfenadine closely in time with those for either ketoconazole or erythromycin. |
| PubMed: | Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. |
| PubMed: | Diagnosis and treatment of tinea versicolor. |
| PubMed: | Coprescription of terfenadine and erythromycin or ketaconazole: an assessment of potential harm. |
| PubMed: | How 'bout that ritonavir? |
| PubMed: | Post-antibiotic effect and post-expositional polyene antagonism of azole antifungal agents in Candida albicans: dependence on substance lipophilia. |
| PubMed: | Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard. |
| PubMed: | Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. |
| PubMed: | Similarity of metabolism for CAI (NSC 609974) in human liver tissue in vitro and in humans in vivo |
| PubMed: | The systemic treatment of onychomycosis. |
| PubMed: | Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences. |
| PubMed: | Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. |
| PubMed: | Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat. |
| PubMed: | Pharmacokinetic optimisation of oral antifungal therapy. |
| PubMed: | Is QT interval prolongation harmful? A regulatory perspective. |
| PubMed: | A banner year for AIDS therapy. |
| PubMed: | Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. |
| PubMed: | Resolution of generalized dermatophytosis without treatment in dogs. |
| PubMed: | Special drug communication teleconference. August 7, 1992. |
| PubMed: | Drug interactions: part II. |
| PubMed: | Is there a role for fluconazole in the treatment of vulvovaginal candidiasis? |
| PubMed: | Ketoconazole for treatment of dermatophytosis in cats. |
| PubMed: | Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis. |
| PubMed: | Impaired intestinal function in symptomatic HIV infection. |
| PubMed: | Azoles and AIDS. |
| PubMed: | Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole. |
| PubMed: | Diseases and drugs but not food decrease ketoconazole 'bioavailability'. |
| PubMed: | The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. |
| PubMed: | [Prevention of bacterial infections after bone marrow graft by broad-spectrum oral antibiotics, absorbable (pefloxacin, penicillin) and non absorbable (cephalosporin, gentamycin, bacitracin)]. |
| PubMed: | Effect of food and gastric acidity on absorption of orally administered ketoconazole. |
| PubMed: | Clinical pharmacokinetics of ketoconazole. |
| PubMed: | Effects of ketoconazole on cholesterol synthesis and precursor concentrations in the rat liver. |
| PubMed: | The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. |
| PubMed: | Trichosporonosis in patients with neoplastic disease. |
| PubMed: | Pharmacologic review: a review of the literature of ketoconazole therapy in the treatment of tinea pedis and onychomycosis. |
| PubMed: | Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. |
| PubMed: | Influence of food on the pharmacokinetics of ketoconazole. |
| PubMed: | Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. |
| PubMed: | Ketoconazole. |
| PubMed: | Prophylaxis of fungal infections in neutropenic cancer patients. |
| PubMed: | Hepatotoxic potential of ketoconazole under investigation. |
| PubMed: | Impairing effect of food on ketoconazole absorption. |
| PubMed: | Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. |
|